Pfizer withdraws sickle cell drug Oxbryta over safety concerns (NYSE:PFE) | Seeking Alpha

Retrieved on: 2024-09-25 22:56:27

Tags for this article:

Click the tags to see associated articles and topics

Pfizer withdraws sickle cell drug Oxbryta over safety concerns (NYSE:PFE) | Seeking Alpha. View article details on hiswai:

Excerpt

Pfizer (PFE) has voluntarily withdrawn all lots of its sickle cell disease drug Oxbryta, also known as voxelotor, over safety concerns.

Article found on: seekingalpha.com